Novartis AG agreed to buy biotechnology company Avidity Biosciences Inc. in a deal that values it at $12 billion, according to the Swiss drugmaker.
www.bloomberg.com
#Novartis #Agrees #Buy #Avidity #Biosciences #Billion #Deal
Novartis Agrees to Buy Avidity Biosciences in $12 Billion Deal
